DNA Software

Ann Arbor, United States Founded: 2000 • Age: 26 yrs
Technologies for developing diagnostic assays and therapeutics are provided.

About DNA Software

DNA Software is a company based in Ann Arbor (United States) founded in 2000. DNA Software offers products and services including PanelPlex™, Visual OMP™, Consensus™, and CopyCount™. DNA Software operates in a competitive market with competitors including DNAnexus, Genomics, Seven Bridges Genomics, Depixus and Ingenuity Systems, among others.

Key Metrics
  • Latest Funding Round
    $1.17M (USD), Grant

    Apr 2011

  • Investors

Products & Services of DNA Software

DNA Software offers a comprehensive portfolio of products and services, including PanelPlex™, Visual OMP™, Consensus™, and CopyCount™.

PanelPlex™
Design Software

Automates multiplex PCR panel design for oncology applications.

Visual OMP™
Simulation Software

Simulates and optimizes PCR assays for better specificity.

Consensus™
Panel Design Software

Facilitates consensus panel design for diagnostic assays.

CopyCount™
Analysis Software

Fits qPCR curves to determine DNA copy numbers.

Funding Insights of DNA Software

  • Total Rounds 8
  • Last Round Grant — $1.17M
  • First Round $299,930

    (Dec 2007)

  • Investors Count 1

All 8 funding rounds of DNA Software with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2011$1.17MGrant––
Aug 2010$847,762Grant––
Apr 2010$1.01MGrant––
Apr 2010$818,893Grant––
Jan 2009$837,629Grant––
Sep 2008$818,893Grant––
Aug 2008$1.01MGrant––
Dec 2007$299,930Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in DNA Software

DNA Software has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov-
Premium access

Investor details for DNA Software

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of DNA Software

11 people are tracked at DNA Software (5 in leadership, 2 in board & advisors, 4 in team).

NameRoleGroup
Rashad Khaddaj
Marketing Director & Strategic Economic AnalystLeadership
John SantaLucia
Director & CEOLeadership
Jun Jiang
Director, Assay DevelopmentLeadership
Joe Johnson
Vice President, Business DevelopmentLeadership
Joseph A. Johnson
Director & VP, Business DevelopmentLeadership
John Carter
DirectorBoard & advisors
Mohammad Hamid
DirectorBoard & advisors
Matt Olson
Technical & Automation SupervisorTeam
Holly SantaLucia
Research Scientist/ Lab ManagerTeam
Dominic Mier
Field Applications Specialist/scientistTeam
Miranda Wright
Research Scientist 1Team
Premium access

Complete people profiles for DNA Software

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of DNA Software

3 dated milestones of DNA Software across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded DNA Software is founded.
  2. Funding First funding round of $300K.
  3. Funding Latest funding round, Grant, of $1.2M.

Competitors of DNA Software

DNA Software operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Genomics, Seven Bridges Genomics, Depixus and Ingenuity Systems, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
dnanexus.com2009Mountain View, United States$472.55M143
Cloud-based genome informatics and data management are provided.
genomics.com2014Oxford, United Kingdom$115.54M–
Genomic risk assessment and prevention platform is provided.
sevenbridges.com2009Cambridge, United States$113M112
Cloud-based platform to analyze, store, and act on genomic data.
depixus.com2012Paris, France$34.52M–
Single-molecule genetic and epigenetic sequencing solutions are provided.
ingenuity.com1998Redwood, United States$20.4M30
Genomic data is analyzed and interpreted via web-based applications.
eaglegenomics.com2008Cambridge, United Kingdom$38.73M–
Developer of cloud-based software solutions for genomic analysis
bcplatforms.com1997Zurich, Switzerland$47.15M8
Platforms for genomic data analysis and management are provided.
deepgenomics.com2015Toronto, Canada$237.96M–
Machine learning is utilized for precision medicine and genetic diagnostics.
twinstrandbio.com2015Seattle, United States$84.02M70
DNA sequencing technology is developed to detect genomic mutations.
Premium access

Detailed competitors of DNA Software

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of DNA Software

The website of DNA Software (dnasoftware.com) receives about 10.9K visits a month.

  • Monthly visits
    10.9K

    ▲ 164.5% vs previous month

Similar websites

Websites whose visitors overlap most with DNA Software. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
perennialsoftware.com
100%
1.8K–View details
dnastar.com
98%
18.1K#1,542,465View details

Similar companies to DNA Software

10 companies that operate in the same segment as DNA Software (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M2,020
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 3.22 BUSD 147.17 M1,000
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M265
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • âś“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • âś“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • âś“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about DNA Software

DNA Software was founded in 2000 and raised its 1st funding round 7 years after it was founded.

DNA Software is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.

DNA Software offers technologies that enable customers to develop diagnostic assays and therapeutics. Products include Oligonucleotide Modeling Platform; OligoKS - Oligo Kinetics Simulator for oligonucleotide hybridization kinetics and competing unimolecular folding kinetics; CopyCount - a qPCR analysis software; ThermoBLAST - tool to find mis-hybridization sites ans eliminate false positives in PCR; Visual OMP - a multiplex PCR primer design software; and OMP Developer Edition - a programmable predictive modeling environment, which can be used to develop customer-specific applications that access the computational and storage capacity of a local server. The DNA Software Application Portal is powered by the Amazon Web Services (AWS) Elastic Compute Cloud (EC2) service.

DNA Software's top competitors include DNAnexus, Eagle Genomics and Depixus.

DNA Software offers PanelPlex™, Visual OMP™, Consensus™, and CopyCount™.

DNA Software has 1 investor. Key investors include HHS.

DNA Software operates through Dna Software, Llc.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available